Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Discontinuation of proton pump inhibitor (PPI) therapy after esophagitis has healed does not worsen heartburn symptoms or cause persistent hypergastrinemia, according to a…
NEW YORK (Reuters Health) – The response of adolescents with migraine to treatment with combination sumatriptan and naproxen sodium is similar to that seen in adults, with no…
NEW YORK (Reuters Health) – Intensive treatment of type 2 diabetes that’s detected early through screening does not seem to reduce rates of subsequent complications, a Danish study…
NEW YORK (Reuters Health) – The beta-blocker propranolol is superior to traditional first-line oral corticosteroids in the treatment of infantile hemangiomas (IHs), conclude pediatric dermatologists from Miami, Florida.…
NEW YORK (Reuters Health) – Use of vasopressin provides no overall benefit in the resuscitation of cardiac arrest patients, but it may improve outcomes in a subset of…
NEW YORK (Reuters Health) – Premature infants who are placed on initial empirical antibiotic therapy for 5 days or longer are at increased risk for late-onset sepsis, necrotizing…
NEW YORK (Reuters Health) – In hemodynamically stable preterm infants, there seems to be minimal clinical benefit to giving a single dose of furosemide right before packed red…
NEW YORK (Reuters Health) – Nearly 1 in 5 cancer patients treated with cisplatin-based chemotherapy have a thromboembolic event within a month of ending treatment, according to a…
NEW YORK (Reuters Health) – Among children between 24 and 59 months of age, vaccination with trivalent inactivated influenza vaccine (TIV) is not associated with any serious adverse…
NEW YORK (Reuters Health) – A new clinical practice guideline recommends bronchodilator monotherapy for patients with chronic obstructive pulmonary disease and an FEV1 less than 60% predicted. The…
